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Background: The recommended dietary allowance (RDA) for protein intake has been set at 1.0-1.3 g/kg/day
for senior. To date, no consensus exists on the lower threshold intake (LTI = RDA/1.3) for the protein intake (PI)
needed in senior patients ongoing both combined caloric restriction and physical activity treatment for metabolic
syndrome. Considering that age, caloric restriction and exercise are three increasing factors of protein need,
this study was dedicated to determine the minimal PI in this situation, through the determination of albuminemia
that is the blood marker of protein homeostasis.
Methods: Twenty eight subjects (19 M, 9 F, 61.8 ± 6.5 years, BMI 33.4 ± 4.1 kg/m2) with metabolic syndrome
completed a three-week residential programme (Day 0 to Day 21) controlled for nutrition (energy balance of
−500 kcal/day) and physical activity (3.5 hours/day). Patients were randomly assigned in two groups: Normal-PI
(NPI: 1.0 g/kg/day) and High-PI (HPI: 1.2 g/kg/day). Then, patients returned home and were followed for six months.
Albuminemia was measured at D0, D21, D90 and D180.
Results: At baseline, PI was spontaneously 1.0 g/kg/day for both groups. Albuminemia was 40.6 g/l for NPI and
40.8 g/l for HPI. A marginal protein under-nutrition appeared in NPI with a decreased albuminemia at D90 below
35 g/l (34.3 versus 41.5 g/l for HPI, p < 0.05), whereas albuminemia remained stable in HPI.
Conclusion: During the treatment based on restricted diet and exercise in senior people with metabolic syndrome,
the lower threshold intake for protein must be set at 1.2 g/kg/day to maintain blood protein homeostasis.
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The International Diabetes Federation (IDF) defines the
metabolic syndrome (MS) as the co-occurrence of any
three of the five following abnormalities : abdominal
obesity (waist circumference > 94 cm in men and> 80 in
women), dyslipidemia (triglyceridemia > 1.5 mmol/l, HDL
cholesterol < 0.4 g/l in men and< 0.5 g/l in women), blood
pressure (BP) > 130/85 and/or medical treatment, and
fasting glycemia > 5.55 mmol/l and/or medical treatment* Correspondence: fred_dutheil@yahoo.fr
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reproduction in any medium, provided the or[1]. MS is associated with an increased risk of cardiovas-
cular diseases [2] and prevalence of type 2 diabetes [3].
In developed countries, its increasing prevalence is mainly
linked to obesity and age [4].
The most efficient strategy to counteract MS is a sig-
nificant reduction in caloric intake associated with an
increase in physical activity (PA). Such programmes aim
primarily to reduce overweight, the most visible mani-
festation of MS, but the challenge is to reduce the fat
mass without affecting lean body mass, especially in se-
nior, for whom a progressive loss of muscle mass and
strength is a natural phenomenon [5], even in those who
are healthy and physically active [6]. In addition, the
recovery of skeletal muscle mass in ageing people is
impaired after a catabolic state [7,8]. Physical exerciseLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in preventing muscle loss. However, there is no consen-
sus on the adequate level of protein intake in the case
of senior patients undergoing a combined treatment of
caloric restriction and physical activity (PA) for MS.
In these patients, age, exercise and energy restriction
increase protein requirement.
The recommended dietary protein allowance (RDA)
for the general population has been set at 0.8 g/kg/day
[9,10]. RDA is defined as the average daily dietary intake
level that is sufficient to meet the nutrient requirements
of nearly all healthy individuals. RDA corresponds to the
mean lower threshold intake (LTI) of a panel of healthy
people plus two standard deviations, including 97.5% of
the population, and is calculated as 1.3 LTI day [9].
Some guidelines recommend increasing RDA to
1.0–1.3 g/kg/day in senior [11].
PA increases the need for proteins whatever the age of
the subject [9,12,13], and this specificity must be taken
into account in senior people [14,15].
Total energy intake has a protein sparing effect [16-18].
Conversely insufficient energy intake will increase the
protein needed to compensate for the energy deficit. As
skeletal muscle is the main storage site of body proteins
and amino acids, this will lead to an undesirable reduc-
tion of muscle mass [19]. Excessive protein intake is of
no value, in particular because it will over-exert the kid-
ney [20] and increase the end products of protein metab-
olism (urea and uric acid). It will also increase the intake
of undesirable saturated fatty acids via proteins of animal
origin [21]. The precautionary principle is to bear this
factor in mind in senior patients, since age-related renal
insufficiency is common [22], especially in people with
elevated BP [23] and/or dyslipidemia [24], which is often
the case in subjects with MS.
The challenge for the prescriber is to give neither too
much nor too little protein, in order to preserve the
muscle mass without inducing harmful effects on the
kidney in older subjects with MS.
Our aim in the present study was to assess the min-
imal need for proteins in a population of senior MS sub-
jects. There are a limited number of tools to assess the
appropriate level of protein intake. One way is to control
preservation of muscle mass over a long period, but this
can only be done in animal studies for ethical reasons.
Nitrogen balance studies are probably the gold standard,
but they are rather cumbersome to perform. Monitoring
the levels of albumin, the blood marker of protein me-
tabolism homeostasis, seems to be the most convenient
index and was chosen for this study. Moreover, albumin
levels are closely linked to morbidity, and represent a
large consensus to assess nutritional status [25,26]. We
decided to determine protein LTI by recording albumin
levels in older subjects with MS participating in a weightreduction programme including exercise and energy
restriction. The programme comprised two parts: a
three-week residential programme during which subjects
stayed in a medical establishment on a controlled diet
with regular PA, and a six-month follow-up at home.
Subjects and methods
Participants
We needed to recruit between 25 and 30 volunteers, of
both sexes, aged from 50 to 70 years, presenting the
characteristics of the MS as defined by the IDF criteria
in 2005 [1]. Potential participants underwent a compre-
hensive medical screening procedure. Volunteers were
eligible for inclusion in the study if they had a sedentary
lifestyle, and stable body weight over the previous year
(i.e., had not fluctuated more than 2 kg), and if their
medical treatment had remained the same during the
6 months before recruitment. Major criteria for exclu-
sion were the presence of cardiovascular, hepatic, renal
or endocrine diseases, the use of medications that affect
body weight, restricted diet in the past year, insufficient
motivation as assessed by interview, and inability to
complete a maximal exercise tolerance test (VO2max).
Of the 33 participants with MS recruited by their
general practitioner, 4 were unable to complete a
maximal exercise tolerance test (VO2max) and 1 had a
pathological response. Twenty eight volunteers, 19 men,
9 women, aged 61.8 ± 6.5 years, were included. All were
Caucasians. They were randomly assigned to two groups
of different PI, normal and high. They all completed the
study (Figure 1).
The study was approved by the local “Committee for the
Protection of the Person for Research in Biology” (CPPRB).
All participants gave written informed consent. They were
informed that the study would be comparing diets with two
different protein intakes and that they would be assigned
a diet at random. Random assignments to one of two dif-
ferent protein intake groups were computer-generated
after subjects were considered eligible to take part.
Study outcomes
The primary outcome was the change from baseline in
albumin levels. Secondary outcomes included other mar-
kers of protein intake such as body composition, in par-
ticular lean mass, creatinine levels, renal clearance and
pro-inflammatory factors such as C-Reactive Protein
(CRP) and orosomucoid.
Study design
In this 26-week study, participants were randomly
assigned, with stratification according to sex and weight,
to one of two groups: a normal PI group (NPI) with
intake of 1.0 g/kg/d and a high PI group (HPI) with
1.2 g/kg/d.
Recruited by general practitioner
n = 33




n = 28 Randomized
5 Excluded (4 Not completed






n = 14 
Figure 1 Flow chart of the study design.
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prised three chronological stages: Day 0 (D0), a 3-week resi-
dential programme (Day 0 to Day 21) and at-home follow
up (D20 to D180). Clinical, biological and body composition
parameters were measured at D0, D20, D90 and D180.
At D0
Basal metabolic rate (BMR) was calculated by the equa-
tions of Black [27]: BMR= 0.963 . weight0.48 . height0.50 .
age-0.13 for women, BMR=1.083 . weight0.48 . height0.50 .
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Figure 2 Study design: The two groups of volunteers (Normal and High p
standardized and personalized diet and physical activity. Thereafter they re
activity, the latter being accompanied by a weekly session of physical activ
intake.(weight, size height, BMI, waist circumference, blood
pressure), body composition and biological parameters
were measured. Before commencing the study, patients
completed questionnaires concerning their food intake
and PA over the previous week. Daily energy intake
(DEI) and daily energy expenditure (DEE) were esti-
mated from the self reported questionnaires. The food
intake questionnaires identified possible deficiencies.
During the three-week residential programme
The subjects carried out daily individually adapted phys-
ical activities with a coach: walking (2 hours), aquagym
(1 h, 3 times/week), keep fit activity (1 h, 3 times/week).
Exercise intensity was fixed between 40 and 60% of the
heart rate reserve (maximum theoretical heart rate –
resting heart rate), by a heart rate recorder (Polar 4000).
They followed the same programme between both groups
six days a week. On the 7th day they only walked. Daily
throughout the residential program, the patients received
both standard and personalized balanced meals drawn up
by dieticians. Their total daily food intake was calculated
in order to reach a negative energy balance (EB=DEE -
DEI) of 500 kcal/day. They also attended lectures on the
MS, nutrition physiology, cooking and physical-activity.
The aim of this educational support was to make them
aware of the lifestyle they would need to adopt in order
to maintain the beneficial effects of the regimen followed.
From D20 to D180
The subjects returned home and were left in charge of
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diet. Thereafter, PA sessions were organized once a week
(keep fit activity or aquagym) to maintain compliance with
the programme. They completed a questionnaire twice a
month on their PA and eating habits. A dietician and a
physical coach could be contacted if they had any queries.
Methods
Clinical follow up was performed by a physician and psy-
chological follow-up to verify the treatment acceptance
was assessed by a psychologist. Daily energy intake (DEI)
and physical activity index were based on questionnaires
before and after the residential programme (three-day
food intake and PA recorded once every 15 days). DEE
was quantified by recording the time and intensity of
each PA and the physical activity index (PAI =DEE/Table 1 Baseline characteristics of participants*
Characteristic Normal protein intake
Age – years 62.9 ± 6.9
Male (M) : n (%) 10 (71)
Female (F) : n (%) 4 (29)
Weight (kg) – M 90.4 ± 8.7
Weight (kg) - F 90.0 ± 18.7
BMI (kg/m2) 32.1 ± 4.2
MS parameters
BMI (kg/m2) 32.1 ± 4.2
Waist circumference (cm) – M 106.5 ± 7.7
Waist circumference (cm) – F 101.5 ± 5.8
Blood Pressure (mmHg) 137/83 ± 11/5
Triglycerides (mmol/l) 1.68 ± 1.15
HDL (mmol/l) 1.44 ± 0.42
Glycemia (mmol/l) 6.15 ± 1.86
Use of medication: n (%)
Antihypertensive agents 5 (36)
Lipid lowering drugs 3 (21)
Hypoglycemiant drugs 3 (21)
Basal Metabolic Rate 1626 ± 178
Daily Energy Expenditure (kcal/d) 1983 ± 229
Physical Activity Index 1.22 ± 0.09
Daily Energy Intake (kcal/d) 2073 ± 556
Daily Energy Intake (kcal/kg/d) 23.8 ± 6.5
Percentage of each macronutrient in the food
% Carbohydrates 39.2 ± 5.5
of high glycemic index carbohydrates 13.9 ± 5.3
% Lipids 44.5 ± 4.7
% Proteins 16.3 ± 1.5
Protein intake (g/kg/d) 0.91 ± 0.26
*: Plus–minus values are means ± SD.BMR) was calculated [28]. Each day during the residen-
tial programme, the patients received both standard and
personalized balanced meals drawn up by dieticians. The
aim was to restore macronutrient balance: 30 to 35%
lipids, 15 to 20% proteins and carbohydrates for the rest.
The PI difference of 0.2 g/kg/d between NPI and HPI
represented, for a mean weight of 80 kg, about 16 g/d of
protein per participant, a difference of 64 kcal/day. This
difference was compensated for by the addition of the
same quantity of carbohydrates for the NPI group. In
both groups, daily PA was programmed for each subject
to obtain a PAI equal to 1.4 [28,29].
Biometry and anthropometry
All subjects underwent medical examinations. Body height
was measured with a stadiometer, BMI was calculated as(n = 14) High protein intake (n= 14) Significance
60.6 ± 6.0 NS
9 (64) NS
5 (36) NS
96.3 ± 4.1 NS
88.7 ± 14.5 NS
35.2 ± 4.2 NS
35.2 ± 4.2 NS
104.3 ± 18.5 NS
100.6 ± 9.2 NS
135/86 ± 18/13 NS
1.88 ± 0.55 NS
1.06 ± 0.33 NS






1.19 ± 0.12 NS
1921± 348 NS
21.2 ± 4.9 NS
40.5 ± 6.0 NS
13.0 ± 1.2 NS
41.9 ± 4.4 NS
17.6 ± 2.7 NS
0.90 ± 0.22 NS
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height in meters. Waist circumference and BP were
recorded. Body composition was assessed by dual energy
X-ray absorptiometry (DXA) (Hologic QDR Delphi series;
Waltham, USA). The in vivo coefficients of variation were
4.2 and 0.48% for fat and lean mass, respectively. Central
fat, (as a surrogate for visceral fat), was assessed by DXA,
which measured the % fat in a rectangle from the upper
edge of the second lumbar vertebra to the lower edge of
the fourth lumbar vertebra. The vertical sides of this area
were the continuation of the lateral sides of the rib cage
[30]. All measurements for a given parameter were made
by the same investigator.
Biochemical measurements
Fasting blood samples were taken between 6.30 and
7.30 a.m., aliquoted and stored at −80°C until anal-
yses. Basic biological examinations (glucose, lipid, cre-
atinine, CRP and orosomucoid levels) were performed in
the biochemistry laboratory of the University Hospital.
Renal clearance was assessed by Cockcroft’s formula [31].
Statistical analysis
Gaussian distribution of the data was tested by the
Kolmogorov-Smirnov test. Data are presented as
means ± standard error (SE). Significance was accepted
at the p < 0.05 level. Statistical procedures were per-
formed by SPSS Advanced Statistics software version 17
(SPSS Inc., Chicago, IL).
Using the method described by Howell [32], we cal-
culated the number of subjects needed for a significant
change in albumin levels between groups (based upon
preliminary data). The minimum number was 10 parti-
cipants per group for a p < 0.05 and a type II error of
10%. Under these conditions the statistical power was
90%.Table 2 Changes in food intakes: percentage of each macron
Variable Groups D0
% Carbohydrates NPI 39.2 ± 5.5
HPI 40.5 ± 6.0
% Lipids NPI 44.5 ± 4.7
HPI 41.9 ± 4.4
% Proteins NPI 16.3 ± 1.5
HPI 17.6 ± 2.7
Protein Intake (g/kg/d) NPI 0.91 ± 0.26
HPI 0.90 ± 0.22
All calculations were done on Bilnut program using CIQUAL (S.C.D.A. Nutrisoft, Le H
* : p < 0.05 to compare the percentage change between D0 and D20, D90 and D18
the Bonferroni test.
† : p < 0.05 to compare the value at the follow-up time with the baseline value (D0)
of variance.
{ : p < 0.05 to compare the value at the follow-up time with the end of the resident
repeated-measures analysis of variance.Baseline characteristics were compared by analysis of
variance or Fisher’s exact test. Longitudinal changes be-
tween groups were tested with the use of mixed-model
repeated-measures analysis of variance, with adjustment
for baseline values and sex. The primary focus of the
analyses was the 3-month change in albumin levels in
the two groups.
In the event of interaction between the repeated mea-
surements (time effect) and the main factor (group of
protein intake), the changes within a group were ana-
lyzed either by a Newman-Keuls post-hoc test for nor-
mally distributed data, or a nonparametric Wilcoxon
test for non-normally distributed data.
Relationships between energy balance, physical activity
and other data were assessed either by Pearson correl-
ation or by multiple regression analysis.
Results
Descriptive characteristic of participants at baseline
The descriptive characteristics of volunteers before the
residential programme are presented in Table 1. There
was no difference at baseline between groups. Usual
food intake as indicated on questionnaires revealed that
all patients of both groups had high lipid and low carbo-
hydrate consumption, with a high ratio of high/low gly-
cemic index (Table 1). Mean cholesterol consumption
was 341 ± 97 mg/d. The mean DEE before the residential
programme was 1983 ± 228 kcal/day corresponding to a
low PAI of 1.22 ± 0.09.
Descriptive characteristics during the residential
programme
Intervention
Food intake over the six months is presented in Table 2,
and energy balance and PAI in Table 3. DEI decreased
and DEE increased during the residential programme,utrient (carbohydrates, lipids, proteins)
D20 D90 D180
48.3 ± 2.5† 42.5 ± 4.6† 39.1 ± 3.4
47.3 ± 3.2† 41,6 ± 4.6 39.5 ± 4.0
32.8 ± 2.1† 38.2 ± 4.7 41.7 ± 3.6
28.7 ± 3.4† 35.5 ± 5.2 38.1 ± 5.6
18.9 ± 0.8* 19.4 ± 0.19†* 19.4 ± 1.3†*
24.8 ± 1.6†* 23.0 ± 2.3†* 22.2 ± 2.2†*
0.95 ± 0.11* 0.94 ± 0.19* 0.96 ± 0.17*
1.19 ± 0.13†* 1.10 ± 0.14†{* 1.09 ± 0.20†{*
allier 37390 Cerelles, France).
0 in the two groups (High Protein Intake versus Normal Protein Intake) using
within each group, as calculated by mixed-model repeated-measures analysis
ial programme (D20) within each group, as calculated by mixed-model
Table 3 Changes in energy balance, physical activity index, MS parameters and body composition during the
residential programme and follow-up for the two groups of protein intake (PI): Normal (NPI) and High (HPI) with
respectively a PI at 1.0 g/kg/day and 1.2 g/kg/day
Variable Groups D0 D20 D90 D180
Body composition measured by DEXA:
Weight (kg) NPI 90.3 ± 11.6 86.5 ± 11.0† 84.4 ± 11.1†{ 85.4 ± 12.1†{
HPI 94.1 ± 15.2 90.7 ± 14.5† 87.1 ± 13.6†{ 86.4 ± 15.0†{
BMI (kg/m2) NPI 32.1 ± 4.2 30.7 ± 3.8† 29.9 ± 3.5†{ 30.3 ± 3.7†{
HPI 35.2 ± 4.2 33.9 ± 4.1† 32.6 ± 4.3†{ 32.4 ± 4.7†{
Lean (kg) NPI 58.287 ± 7.47 57.323 ± 7.56† 56.488 ± 7.89† 56.798 ± 7.99†
HPI 56.594 ± 11.04 55.987 ± 10.32 55.223 ± 10.57† 55.137 ± 10.47†
Total fat (kg) NPI 29.542 ± 9.75 26.737 ± 9.38† 25.524 ± 8.94† 26.213 ± 9.580†
HPI 35.229 ± 8.25 32.474 ± 7.72† 29.598 ± 7.68†{ 29.068 ± 9.18†{
Visceral fat (kg) NPI 3.277 ± 1.24 2.839 ± 1.22† 2.695 ± 1.07† 2.527 ± 1.01†{
HPI 3.295 ± 0.88 2.916 ± 0.79† 2.662 ± 0.75† 2.445 ± 0.71†{
Fat percentage (%) NPI 32.3 ± 7.9 30.5 ± 8.3† 29.9 ± 8.2† 30.2 ± 8.3†
HPI 37.4 ± 6.1 35.7 ± 5.9† 34.0 ± 6.6† 33.4 ± 7.2†
Energy Balance (kcal/d) NPI + 92 ± 521 −751± 147† −521± 304†{ −413 ± 304{
HPI + 34 ± 348 −635± 102† −524± 83†{ −444 ± 71{
Physical Activity NPI 1.22 ± 0.09 1.42 ± 0.07† 1.31 ± 1.97†{ 1.30 ± 0.07†{
HPI 1.19 ± 0.12 1.40 ± 0.09† 1.33 ± 1.82†{ 1.28 ± 0.04†{
Metabolic Syndrome parameters:
Waist circumference (cm) NPI 105.1 ± 7.4 102.7 ± 7.9†{ 99.2 ± 6.3†{ 98.9 ± 7.4†{
HPI 101.6 ± 11.8 97.2 ± 9.6†{ 95.1 ± 9.9†{ 93.3 ± 9.1†{
Blood Pressure (mmHg) NPI 137/83 ± 11/5 130†/80 ± 13/5 129†/80 ± 15/6 132/78 ± 16/9
HPI 135/86 ± 19/13 128†/80 ± 15/16 125†/85 ± 16/18 127/82 ± 20/16
Triglycerides (mmol/l) NPI 1.68 ± 1.15 1.19 ± 0.34 1.17 ± 0.40 1.27 ± 0.61
HPI 1.88 ± 0.55 1.37 ± 0.26 1.85 ± 0.21 1.86 ± 1.07
HDL (mmol/l) NPI 1.44 ± 0.42 1.49 ± 0.31 1.31 ± 0.31{ 1.58 ± 0.46
HPI 1.06 ± 0.33 1.02 ± 0.29 1.13 ± 0.33 1.14 ± 0.25
Glycemia (mmol/l) NPI 6.15 ± 1.86 6.26 ± 1.76 5.7 ± 1.97{ 6.28 ± 2.34
HPI 5.13 ± 0.68 4.54 ± 0.54† 4.98 ± 0.79 4.92 ± 0.50
Other Lipid parameters:
Total cholesterol (mmol/l) NPI 6.08 ± 1.46 5.07 ± 0.95† 5.13 ± 1.25† 5.56 ± 0.89
HPI 5.79 ± 1.07 4.65 ± 1.09† 6.18 ± 1.60 6.19 ± 1.08
LDL (mmol/l) NPI 3.79 ± 1.21 3.05 ±0.87† 3.47 ± 1.25 3.43 ± 0.95
HPI 3.89 ± 1.01 2.99 ±0.99† 4.21 ± 1.34 4.25 ± 0.97
Albumin levels (g/l) NPI 40.6 ± 3.3 40.3 ± 3.1 34.3 ± 1.8†{* 35.3 ± 2.2†{
HPI 40.8 ± 2.4 41.3 ± 2.6 41.5 ± 2.6* 41.0 ± 3.2*
Pro-inflammatory factors:
CRP (mg/l) NPI 5.09 ± 4.06 3.64 ± 3.69 4.18 ± 5.60 3.68 ± 4.12
HPI 4.19 ± 2.33 3.80 ± 3.48 3.04 ± 3.23 2.99 ± 2.05
orosomucoid (mg/l) NPI 0.85 ± 0.16 0.80 ± 0.19 0.75 ± 0.19 0.84 ± 0.15
HPI 0.91 ± 0.29 0.80 ± 0.33 0.91 ± 0.25 0.84 ± 0.41
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Table 3 Changes in energy balance, physical activity index, MS parameters and body composition during the
residential programme and follow-up for the two groups of protein intake (PI): Normal (NPI) and High (HPI) with
respectively a PI at 1.0 g/kg/day and 1.2 g/kg/day (Continued)
Renal function:
creatinine levels (mmol/l) NPI 89.4 ± 19.9 89.1 ± 18.8 80.1 ± 20.7 81.1 ± 20.4
HPI 84.9 ± 22.2 88.2 ± 24.1 86.1 ± 23.7 84.0 ± 21.3
Cockroft (ml/min) NPI 100.3 ± 28.3 95.4 ± 24.2 107.1 ± 27.9 106.6 ± 32.0
HPI 111.8 ± 23.7 104.5 ± 24.9 106.7 ± 23.4 109.0 ± 24.4
* : p < 0.05 to compare the percentage change between D0 and D20, D90 and D180 in the two groups (High Protein Intake versus Normal Protein Intake) using
the Bonferroni test.
† : p < 0.05 to compare the value at the follow-up time with the baseline value (D0) within each group, as calculated by mixed-model repeated-measures analysis
of variance.
{ : p < 0.05 to compare the value at the follow-up time with the end of the residential programme (D20) within each group, as calculated by mixed-model
repeated-measures analysis of variance.
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PAI was set at 1.4 ± 0.1. Macronutrient distribution
improved: lipid intake was lower and that of carbohy-
drates and proteins higher. There were reduced amounts
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Figure 3 Change from baseline (day 0) to Month 6 (day 180) in album
protein intake (NPI) set at 1.0 g/kg/d and high protein intake (HPI) at
protein intake group. Open bars represent albumin levels or lean mass in N
and B show the change in lean mass and albumin levels, respectively, for a
intake (n= 14) or to a Normal protein intake (n= 14). No missing data.General effects for both groups
At the end of the residential programme, the combination
of diet and PA had significantly reduced body weight,
BMI, waist circumference and systolic BP. Fifty seven
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and triglyceride levels had an overall tendency to decrease
(p< 0.1). Other blood lipid parameters decreased signifi-
cantly at D20 and then returned to baseline levels. Cre-
atinine levels and creatinine clearance, as assessed by
Cockroft’s formula remained stable (Table 3).
Following the residential programme, dietary recom-
mendations were given every 15 days to maintain a
negative energy balance. The patients gradually went
back to their former eating habits with increased lipid
intake and a reduction in carbohydrates. Weight loss
and central fat loss continued, as did the reduction in
BMI and waist circumference, with no significant differ-
ence between groups (Table 3).
Main judgment criteria
At D20, there was no significant change in albumin
levels in either group. Following the residential
programme, the levels decreased in NPI group at D90
and D180, to reach the threshold value of 35 g/l consid-
ered as a marker of a protein deficiency. Albumin levels
in the HPI group remained stable throughout the experi-
mental period.
Secondary judgment criteria
In both groups, creatinine levels and creatinine clearance
remained stable at all times, as did CRP and orosomucoid.
Discussion
Our study shows that when PA and nutritional habits
are modified by a healthier lifestyle, there is a significant
improvement in MS criteria (Table 3). When subjects
entered the study, protein intake was about 0.9 g/kg/d,
the level currently considered as adequate for the senior
[10] and albumin levels were normal (Table 3, Figure 3).
As the exercise regimen and the reduced caloric intake
of the programme were expected to increase the protein
LTI, we set protein intake at 1 g/kg/d for NPI and at
1.2 g/kg/d for HPI.
We measured albumin levels at the beginning of the
study (D0) and at D20, D90 and D180 in the two groups
of MS patients older than 50 years. There was no change
in the levels in the HPI group, while in the NPI group,
they were lower at D90. This significant decrease would
probably indicate a too low protein intake in the NPI
group, given the new conditions of PA and overall cal-
oric intake [9,12-14]. In contrast, the PI set at 1.2 g/kg/d
kept albumin levels steady. The fall in level was observed
at D90 only and not at D20, probably due to its long
half-life of 20 days.
A catabolic phase may occur in the event of increased
inflammatory status [33]. In the present study, we moni-
tored this status by assaying CRP, which remained stable
with normal levels in both groups (Table 3). Likewise,altered renal function may be the cause of hypoalbumi-
nemia. This was not the case in our patients, as assessed
by normal and stable renal Cockcroft clearance (Table 3).
Moreover, high protein intake is now considered to be
only a weak risk for renal function in healthy senior
individuals [34]. Finally, all patients were free of medica-
tions which may influence albumin levels.
Consequently, our study shows that LTI (and not
RDA) for protein must be set at 1.2 g/kg/d when
physical activity together with reduced caloric intake are
prescribed to patients suffering from MS. This result
agrees with the findings of Lucas & Heiss [15], who
proposed a RDA of 1–1.3 g/kg/d for older adults
(> 50 years old) engaged in physical training correspond-
ing to a LTI of 0.8 to 1.0 g/kg/day. The addition of
caloric restriction, as in this study, increases LTI for pro-
tein to 1.2 g/kg/d.
Such a level of protein intake may appear high for
people consuming light meals. For an individual weigh-
ing 80 kg, it represents 100 g/day of protein dry weight,
that is to say 500 g of crude protein. Dietary animal pro-
tein is the primary source of high biological value pro-
tein [35]. If fifty percent of protein intake is from animal
origin, this corresponds to 250 g meat or fish per day,
since eggs and cheese are drastically reduced or even
suppressed on account of their high lipid content. We
may also consider that 100 g protein represent 400 kcal.
If the total caloric intake is set at 2000 kcal, proteins will
represent 20% of intake.
Conclusion
This study is a contribution to the quantification of
the optimal protein lower threshold intake for indivi-
duals suffering from metabolic syndrome entering a
programme of weight reduction with controlled diet and
exercise. This is an important issue because insufficient
protein intake could be detrimental when physical activ-
ity is added to a restricted diet. Our study suggests pro-
tein intake should be 1.2 g/kg/d in senior people
suffering from metabolic syndrome and taking part in a
weight loss programme.
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